Relevium Executes LOI to Acquire Montreal Biopharma Contract Manufacturing Company Cannabis Investing News
CB2 Insights Announces Record Revenue of $4.2 million for the Third Quarter 2019, Sequential Growth of 29 Percent Cannabis Investing News
Yield Growth Closes Agreement to License 126 Product Formulas to Subsidiary Flourish Mushroom Labs Cannabis Investing News